BlueBrainBoost
freedom-pharmacy
Purchases through the above links give commission which helps fund this website
Recent literature: Vasopressin receptor 2 antagonist
Date Journal Article title
2019 Feb BMC Pediatr First experience with Tolvaptan for the treatment of neonates and infants with capillary leak syndrome after cardiac surgery.
2019 Exp Hematol Oncol Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma.
2019 Jan Drugs Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease.
2019 Jan Biochimie Vasopressin receptors in islets enhance glucose tolerance, pancreatic beta-cell secretory function, proliferation and survival.
2019 Jan Exp Clin Endocrinol Diabetes Role of Vasopressin Receptor 2 and 3 in ACTH-Secreting Tumors and their Potential Therapeutic Implications.
2019 Jan Dig Dis Positive Response to Tolvaptan Treatment Would Be a Good Prognostic Factor for Cirrhotic Patients with Ascites.
2018 Dec Nephrology (Carlton) Effects of the SGLT2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan.
2018 Dec Am J Kidney Dis Determinants of Urine Volume in ADPKD Patients Using the Vasopressin V2 Receptor Antagonist Tolvaptan.
2018 Dec BMC Nephrol Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease.
2018 Dec BMC Pharmacol Toxicol Impact of continued administration of tolvaptan on cirrhotic patients with ascites.
2019 Hypertens Res Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion.
2018 J Sex Med Cligosiban, A Novel Brain-Penetrant, Selective Oxytocin Receptor Antagonist, Inhibits Ejaculatory Physiology in Rodents.
2019 Drug Metab Dispos Altered Hepatobiliary Disposition of Tolvaptan and Selected Tolvaptan Metabolites in a Rodent Model of Polycystic Kidney Disease.
2018 Nov Int Heart J Effects of Tolvaptan on Volume Overload in Patients with Heart Failure.
2018 Int J Cardiol Heart Vasc Right ventricular enlargement predicts responsiveness to tolvaptan in congestive heart failure patients with reduced ejection fraction.
2019 Neurogastroenterol Motil Vasopressin augments TNBS-induced colitis through enteric neuronal V1a receptor-mediated COX-2-dependent prostaglandin release from mast cells in mice.
2019 Clin Drug Investig Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites.
2018 J Hum Reprod Sci A Prospective Case-control Trial to Evaluate and Compare the Efficacy and Safety of Atosiban versus Placebo in iIn vitroi Fertilization-embryo Transfer Program.
2018 Int J Nephrol Renovasc Dis Effects of tolvaptan on renal function in chronic kidney disease patients with volume overload.
2019 Neuropsychopharmacology Oxytocin attenuates phencyclidine hyperactivity and increases social interaction and nucleus accumben dopamine release in rats.
2018 PLoS One Cardiovascular effects of H3 histamine receptor inverse agonist H4 histamine receptor agonist, clobenpropit, in hemorrhage-shocked rats.
2019 FASEB J Hydrogen sulfide upregulates renal AQP-2 protein expression and promotes urine concentration.
2018 Aug Clin J Am Soc Nephrol Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease.
2018 Sep J Neurophysiol Detection of activity-dependent vasopressin release from neuronal dendrites and axon terminals using sniffer cells.
2018 Jul BMC Nephrol Case report: a thiazide diuretic to treat polyuria induced by tolvaptan.
2018 Jun Cochrane Database Syst Rev Interventions for chronic non-hypovolaemic hypotonic hyponatraemia.
2018 Dec Mol Cell Endocrinol Oxytocin alters the morphology of hypothalamic neurons via the transcription factor myocyte enhancer factor 2A (MEF-2A).
2018 Neuropeptides Selective and non-selective OT receptor agonists induce different locomotor behaviors in male rats via central OT receptors and peripheral V1a receptors.
2018 Nov Mil Med A Non-Comparative Prospective Pilot Study of Ketamine for Sedation in Adult Septic Shock.
2018 May J Neuroendocrinol Effects of calcium and sodium on ATP-induced vasopressin release from rat isolated neurohypophysial terminals.
2018 Nat Neurosci Complex formation between the vasopressin 1b receptor, β-arrestin-2, and the μ-opioid receptor underlies morphine tolerance.
2018 Heart Vessels The effects of tolvaptan dose on cardiac mortality in patients with acute decompensated heart failure after hospital discharge.
2018 Nephrology (Carlton) Tolvaptan alleviates excessive fluid retention of nephrotic diabetic renal failure unresponsive to furosemide.
2018 May Anal Biochem Quantification of receptor activation by oxytocin and vasopressin in endocytosis-coupled bioluminescence reduction assay using nanoKAZ.
2018 Apr Arch Argent Pediatr [Tolvaptan in a pediatric cardiorenal syndrome: What is its role?]
2018 Biomed Pharmacother Steviol slows renal cyst growth by reducing AQP2 expression and promoting AQP2 degradation.
2018 Korean J Physiol Pharmacol Oxytocin produces thermal analgesia via vasopressin-1a receptor by modulating TRPV1 and potassium conductance in the dorsal root ganglion neurons.
2018 Medicine (Baltimore) A case report with shock induced by tolvaptan in an elderly patient with congestive heart failure.
2018 J Int Med Res Hormone treatments in congestive heart failure.
2017 Electrolyte Blood Press Edematous Hyponatremia Treated with Tolvaptan in a Patient with Amyotrophic Lateral Sclerosis.
2018 Int Heart J Tolvaptan Improves Prognosis in Responders with Acute Decompensated Heart Failure by Reducing the Dose of Loop Diuretics.
2018 May Neuropharmacology The role of the vasopressin V1A receptor in oxytocin modulation of methamphetamine primed reinstatement.
2018 Jan Ann Transplant Tolvaptan for Fluid Management in Living Donor Liver Transplant Recipients.
2017 Dec Int J Mol Sci Hyaluronan Production by Renomedullary Interstitial Cells: Influence of Endothelin, Angiotensin II and Vasopressin.
2018 Biochem Biophys Rep Proteomic analysis of AQP11-null kidney: Proximal tubular type polycystic kidney disease.
2018 Neuropharmacology Oxytocin inhibits the rat medullary dorsal horn Sp5cC1 nociceptive transmission through OT but not V1A receptors.
2017 ESC Heart Fail Influence of renal impairment on aldosterone status, calcium metabolism, and vasopressin activity in outpatients with systolic heart failure.
2017 Nov N Engl J Med Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
2017 Oct J Clin Med Is Exaggerated Release of Arginine Vasopressin an Endocrine Disorder? Pathophysiology and Treatment.
2018 Heart Vessels Effects of tolvaptan on urine output in hospitalized heart failure patients with hypoalbuminemia or proteinuria.
2018 Jan Neurosci Lett Arginine vasopressin antagonizes the effects of prostaglandin E2 on the spontaneous activity of warm-sensitive and temperature-insensitive neurons in the medial preoptic area in rats.
2017 Horm Behav Oxytocin induces penile erection and yawning when injected into the bed nucleus of the stria terminalis: Involvement of glutamic acid, dopamine, and nitric oxide.
2017 Psychopharmacology (Berl) Role of vasopressin V1a receptor in ∆9-tetrahydrocannabinol-induced cataleptic immobilization in mice.
2018 Heart Vessels Favorable effects of early tolvaptan administration in very elderly patients after repeat hospitalizations for acute decompensated heart failure.
2017 Front Psychiatry The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish.
2017 Aug BMC Vet Res Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
2017 PLoS One Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias.
2017 Jul Proc Biol Sci Early life manipulations of vasopressin-family peptides alter vocal learning.
2017 Aug Int Heart J Mechanisms of Diuresis for Acute Decompensated Heart Failure by Tolvaptan.
2017 J Labelled Comp Radiopharm Radiosynthesis and evaluation of 1-stituted 3-(2,3-dihydro-1H-inden-2-yl)-6-(1-ethylpropyl)-(3R,6R)-2,5-piperazinedione derivatives as PET tracers for imaging the central oxytocinergic system.
2017 Dec Am J Physiol Heart Circ P... Increased activity of the orexin system in the paraventricular nucleus contributes to salt-sensitive hypertension.
2017 Jul Proc Natl Acad Sci U S A Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease.
2017 Jul Drug Discov Ther Experience with long-term administration of tolvaptan to patients with acute decompensated heart failure.
2017 Neuropeptides Arginine vasopressin relates with spatial learning and memory in a mouse model of spinocerebellar ataxia type 3.
2017 Ann Nutr Metab Polycystic Kidney Disease and the Vasopressin Pathway.
2018 Pediatr Nephrol Expanding the role of vasopressin antagonism in polycystic kidney diseases: From adults to children?
2017 J Nucl Med High-Contrast PET Imaging of Vasopressin V1B Receptors with a Novel Radioligand, 11C-TASP699.
2017 Hosp Pract (1995) An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia.
2017 Handb Exp Pharmacol Vasopressin and Vasopressin Antagonists in Heart Failure.
2017 J Diabetes Complications Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes.
2017 J Cell Biochem The Non-Peptide Vasopressin V1b Receptor Antagonist, SSR149415, Ameliorates Spermatogenesis Function in a Mouse Model of Chronic Social Defeat Stress.
2018 Turk Neurosurg Effects of Arginine Vasopressin and V1 Receptor Antagonist on Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage: An Experimental Study.
2018 Mar Nephrol Dial Transplant Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.
2017 PLoS One Prediction of diuretic response to tolvaptan by a simple, readily available spot urine NaK ratio.
2017 J Cell Mol Med The V2 receptor antagonist tolvaptan raises cytosolic calcium and prevents AQP2 trafficking and function: an in vitro and in vivo assessment.